These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2879915)

  • 21. Effects of Anemarrhena asphodeloides on IgE-mediated passive cutaneous anaphylaxis, compound 48/80-induced systemic anaphylaxis and mast cell activation.
    Chai OH; Shon DH; Han EH; Kim HT; Song CH
    Exp Toxicol Pathol; 2013 May; 65(4):419-26. PubMed ID: 22261360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 4-(Indolyl-3)-1-(benzimidazolonylalkyl)-piperidines, a novel group of potential antiallergy compounds.
    Freter K; Fuchs V; Barsumian E; Oliver JT
    Arzneimittelforschung; 1985; 35(1A):272-6. PubMed ID: 2580540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mast cell mediators in citric acid-induced airway constriction of guinea pigs.
    Lin CH; Lai YL
    Toxicol Appl Pharmacol; 2005 Aug; 206(3):343-50. PubMed ID: 16039945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of piperazine derivatives and evaluation of their antihistamine and antibradykinin effects.
    Choo HY; Chung BJ; Chung SH
    Bioorg Med Chem Lett; 1999 Sep; 9(18):2727-30. PubMed ID: 10509924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Degranulation of rat mesentery mast cells by antihistamines: influence of ionization.
    Pini JJ; Vugman I
    Agents Actions; 1978 Oct; 8(5):491-6. PubMed ID: 31077
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibitory effects of atractylone on mast cell-mediated allergic reactions.
    Han NR; Moon PD; Nam SY; Ryu KJ; Yoou MS; Choi JH; Hwang SY; Kim HM; Jeong HJ
    Chem Biol Interact; 2016 Oct; 258():59-68. PubMed ID: 27553716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitrogen bridgehead compounds. 38. New antiallergic 4H-pyrido[1,2-a]pyrimidin-4-ones. 3.
    Hermecz I; Breining T; Vasvári-Debreczy L; Horváth A; Mészáros Z; Bitter I; DeVos C; Rodriguez L
    J Med Chem; 1983 Oct; 26(10):1494-9. PubMed ID: 6137567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous mast cell degranulation modulates cervical contractility in the guinea pig.
    Bytautiene E; Vedernikov YP; Saade GR; Romero R; Garfield RE
    Am J Obstet Gynecol; 2002 Mar; 186(3):438-45. PubMed ID: 11904604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The anti-anaphylactic and histamine-releasing properties of the antihistamines. Their effect on the mast cells.
    MOTA I; da SILVA W
    Br J Pharmacol Chemother; 1960 Sep; 15(3):396-404. PubMed ID: 13773171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acrylamide derivatives as antiallergic agents. I. Synthesis and structure-activity relationships of N-[(4-substituted 1-piperazinyl)alkyl]-3-(aryl and heteroaryl)acrylamides.
    Nishikawa Y; Shindo T; Ishii K; Nakamura H; Kon T; Uno H
    Chem Pharm Bull (Tokyo); 1989 Jan; 37(1):100-5. PubMed ID: 2720841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of antiallergic and anti-anaphylactic activity of ethanolic extract of Sanseveiria trifasciata leaves (EEST) in rodents.
    Andhare RN; Raut MK; Naik SR
    J Ethnopharmacol; 2012 Aug; 142(3):627-33. PubMed ID: 22683909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vardenafil ameliorates immunologic- and non-immunologic-induced allergic reactions.
    El-Awady MS; Said E
    Can J Physiol Pharmacol; 2014 Mar; 92(3):175-80. PubMed ID: 24593781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The inhibition of mast cell damage and histamine release in anaphylaxis by pyridine and diphosphopyridine nucleotidase inhibitors. Comparison with compound 48/80.
    MOTA I; da SILVA W; FERNANDES JF
    Br J Pharmacol Chemother; 1960 Sep; 15(3):405-9. PubMed ID: 13773170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiallergy activity of substituted 11-oxo-11 H-pyrido[2,1-b]quinazoline-8-carboxylic acids.
    Schwender CF; Sunday BR; Herzig DJ; Kusner EK; Schumann PR; Gawlak DL
    J Med Chem; 1979 Jun; 22(6):748-50. PubMed ID: 88523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of 3,4-dihydro-4-oxothieno[2,3-d]pyrimidine-2-carboxylates, a new series of orally active antiallergy agents.
    Temple DL; Yevich JP; Covington RR; Hanning CA; Seidehamel RJ; Mackey HK; Bartek MJ
    J Med Chem; 1979 May; 22(5):505-10. PubMed ID: 88521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of histamine release by compound 48-80.
    Rothschild AM
    Br J Pharmacol; 1970 Jan; 38(1):253-62. PubMed ID: 4189829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiallergic activity and mode of action of N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(6-methyl-3- pyridyl)acrylamide in experimental animals.
    Ishii K; Yakuo I; Seto Y; Kita A; Nakamura H; Nishikawa Y
    Arzneimittelforschung; 1993 Feb; 43(2):148-54. PubMed ID: 7681286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiallergic agents. 2. N-(1H-tetrazol-5-yl)-6-phenyl-2-pyridinecarboxamides.
    Honma Y; Oda K; Hashiyama T; Hanamoto K; Nakai H; Inoue H; Ishida A; Takeda M; Ono Y; Tsuzurahara K
    J Med Chem; 1983 Oct; 26(10):1499-504. PubMed ID: 6137568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The inhibitory effect of phenothiazine stains on rat and guinea-pig mast cell damage induced by antihistamines and compound 48-80.
    Vugman I; do Prado ML
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 279(2):173-84. PubMed ID: 4129541
    [No Abstract]   [Full Text] [Related]  

  • 40. Novel orally active inhibitors of passive cutaneous anaphylaxis in rats: N-[2-(4-pyridinyl)-4-pyrimidinyl]ureas and dialkyl [[[2-(4-pyridinyl)-4-pyrimidinyl]amino]methylene]malonates.
    Lesher GY; Singh B; Mielens ZE
    J Med Chem; 1982 Jul; 25(7):837-42. PubMed ID: 6180166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.